Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-01-22T10:52:08.574Z Has data issue: false hasContentIssue false
  • English
  • Français

In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia

Published online by Cambridge University Press:  19 October 2009

W. Y. Lau ,
C. H. Teoh-Chan ,
S. T. Fan  and
K. F. Lau
W. Y. Lau
Affiliation:
Government Surgical Unit, Queen Mary Hospital
C. H. Teoh-Chan
Affiliation:
Department of Microbiology, University of Hong Kong
S. T. Fan
Affiliation:
Government Surgical Unit, Queen Mary Hospital
K. F. Lau
Affiliation:
Department of Microbiology, University of Hong Kong
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Five hundred strains of methicillin-resistant Staphylococcus aureus were tested against various anti-staphylococcal agents. Vancomycin, fusidic acid and fosfomycin were found to be the most effective. Only 1 strain out of 500 was resistant to fosfomycin. Three patients with methicillin-resistant Staphylococcus aureus septicaemia were successfully treated by fosfomycin. We conclude that fosfomycin could be the drug of choice for methicillin-resistant Staphylococcus aureus infection.

Type
Research Article
Information
Journal of Hygiene , Volume 96 , Issue 3 , June 1986 , pp. 419 - 423
Copyright
Copyright © Cambridge University Press 1986

References

REFERENCES

Allona, A., Diaz, Cabrera J. A. & Manchado, P. (1977). Fosfomycin in chronic urinary infections. Chemotherapy 23, 267–274.CrossRefGoogle ScholarPubMed
Andrews, J. M., Baquero, F., Beltrau, J. M., Canton, E., Crokaert, F., Gobernado, M., Gomez-Lus, R., Loza, E., Navarr, M., Olay, T., Rodriguez, A., Vicente, M. V., Wise, R. & Yourassowsky, E. (1983). International collaborative study on standardization of bacterial sensitivity to fosfomycin. Journal of Antimicrobial Chemotherapy 12, 357–361.Google Scholar
Dai, Z., Zhang, Y., Zhang, M., Zhang, Z., Zhang, J. & Liu, Y. (1981). Reevaluation of fosfomycin. Chinese Medical Journal 94, 645–652.Google ScholarPubMed
Editorial. (1983). Methicillin-resistant Staphylococcus aureus. Journal of Hospital Infection 4, 327–329.Google Scholar
Farber, B. F. & Mollering, R. C. Jr, (1982). Vancomycin toxicity: a study of 100 treatment courses using a modern formulation. In Program and Abstracts of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D. C: American Society for Microbiology.Google Scholar
Gudin, J., Santos, M., Marco, V., Menez, J. L., Baguena, J. & Gobernado, M. (1983). Efficacy of fosfomycin in the treatment of serious infections. In Proceedings of the 13th International Congress of Chemotherapy in Vienna 1983 37, 43–45.Google Scholar
Guenther, S. H. & Wenzel, R. P. (1984). In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 26, 268–269.CrossRefGoogle Scholar
Hutzler, R., Farmandes, V., Munoz, D. & Rozantramb, A. (1977). Activity of fosfomycin in the treatment of bacterial infections. hemotherapy 23, 358–364.Google Scholar
Kestle, D. G. & Kirby, W. M. (1969). Clinical pharmacology and in vitro activity of phosphonomycin. Antimicrobial Agents and Chemotherapy 9, 332–337.Google Scholar
Levine, D. P., Cushing, R. D., Jui, J. & Brown, W. J. (1982). Community-acquired methicillinresistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Annals of Internal Medicine 97, 330–338.CrossRefGoogle ScholarPubMed
Myers, J. P. & Linneman, C. C. Jr (1982). Bacteraemia due to methicillin resistant Staphylococcus aureus. Journal of Infectious Diseases 145, 532–536.CrossRefGoogle ScholarPubMed
Neuman, M. (1984). Recent developments in the field of phosphoric acid antibiotics. Journal of Antitnicrobial Chemotherapy 14, 309–311.Google Scholar
Peacock, J. K., Moorman, D. E., Wenzel, R. P. & Mandell, G. L. (1981). Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities and assessment of virulence of an epidemic strain. Journal of Infectious Diseases 144, 575–582.CrossRefGoogle ScholarPubMed
Rodriguez, A., Olay, T. & Vicente, M. V. (1980). Synergic activity of fosfomycin in association with other anti-bacterial agents: a review. Drugs Experimental Clinical Research 6, 281–288.Google Scholar
Rodriguez, A., Olay, T. & Vicente, M. V. (1983). Evaluation of fosfomycin in the treatment of severe infections: Review. In Proceedings of the 13th International Congress of Chemotherapy in Vienna 1983 37, 46–49.Google Scholar
Sabath, L. D., Wheeler, W., Laverdiere, M., Blazevic, D. & Wilkinson, B. A. (1978). A new type of penicillin resistance of Staphylococcus aureus. Journal of Antimicrobiol Chemotherapy 4, 501–568.Google Scholar
Thompson, R. L., Fisher, K. A. & Wenzel, R. P. (1982). In vitroactivity of N-formimidoyl thienamycin and other β-lactam antibiotics against methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 21, 341–343.Google Scholar
Thompson, R. L. & Wenzel, R. P. (1982). International recognition of methicillin-resistant strains of Staphylococcus aureus. Annals of Internal Medicine 97, 925–929.CrossRefGoogle ScholarPubMed
Watanakunakorn, C. (1982). Treatment of infections due to methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 97, 370–378.Google Scholar
Watanakunakorn, C. (1983). A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis. Scandinavian Journal of Infectious Disease (Supplement) 41, 151–157.Google Scholar
Watanakunakorn, C. & Guerrieuo, J. C. (1981). Interaction between vancomycin and rifampicin against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 19, 1089–1091.Google Scholar
Wenzel, R. P. (1982). The emergence of methicillin-resistant Staphylococcus aureus. Annals of Internal Medicine 97, 440–442.Google Scholar